Supplement overview

American Journal of Surgery

Volumn 176, Issue 2 A, 1998, Pages 3S-4S

  Flint Jr , Lewis M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DIABETIC FOOT; FOOT ULCER; HEALTH CARE COST; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; WOUND CARE; WOUND HEALING;

EID: 0344110397     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00180-9     Document Type: Article

References (7)

1. Laing P. The development and consequences of diabetic foot ulcers. Am J Surg. 1998;176(Suppl 2A):11S-19S.
2. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(Suppl 2A):5S-10S.
3. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998; 176(Suppl 2A):26S-38S.
4. Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg. 1998;176(Suppl 2A):39S-47S.
5. Steed DL. Foundations of good ulcer care. Am J Surg. 1998; 176(Suppl 2A):20S-25S.
6. Wieman TJ, Becaplermin Gel Studies Group. Clincial efficacy of becaplermin (rhPDGF-BB) gel. Am J Surg. 1998;176(Suppl 2A):74S-79S.
7. Robson MC, Mustoe TA, Hunt TK. The future of recombinant growth factors in wound healing. Am J Surg. 1998;176(Suppl 2A): 80S-82S.